Search Result "PD 184352 (CI-1040)"
MEK Inhibitors: A Therapeutic Approach to Targeting the Ras-MAP Kinase Pathway in Tumors
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 1907-1914
Author(s): Judith S. Sebolt-Leopold
Strategies of Development of Antiviral Agents Directed Against Influenza Virus Replication
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 3 Year: 2007 Page: 3531-3542
Author(s): Hsing-Pang Hsieh, John T.-A. Hsu
Agents Targeting Ras Signaling Pathway
Journal: Current Pharmaceutical Design
Volume: 8 Issue: 2 Year: 2002 Page: 2259-2267
Author(s): J. E. Dancey
Highly Selective MEK Inhibitors
Journal: Current Enzyme Inhibition
Volume: 6 Issue: 3 Year: 2010 Page: 146-157
Author(s): Chih-Shia Lee, Nicholas S. Duesbery
ATP Non-Competitive Ser/Thr Kinase Inhibitors as Potential Anticancer Agents
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 7 Year: 2009 Page: 778-786
Author(s): Giorgio Cozza, Andrea Bortolato, Ernesto Menta, Ennio Cavalletti, Silvano Spinelli, Stefano Moro
Beyond Single Pathway Inhibition: MEK Inhibitors as a Platform for the Development of Pharmacological Combinations with Synergistic Anti-Leukemic Effects
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 2 Year: 2005 Page: 2779-2795
Author(s): M. Milella, C. M. Precupanu, C. Gregorj, M. R. Ricciardi, M. T. Petrucci, S. M. Kornblau, A. Tafuri, M. Andreeff
Recent Advances of MEK Inhibitors and Their Clinical Progress
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 1 Year: 2007 Page: 1364-1378
Author(s): Wang John (Yuan), Wilcoxen M. Keith, Nomoto Kenichi, Wu Sara
AIDS Related Viruses, their Association with Leukemia, and Raf Signaling
Journal: Current HIV Research
Volume: 3 Issue: 4 Year: 2005 Page: 319-327
Author(s): Audy G. Whitman, Benjaman A. Bryan, Ossie F. Dyson, Dipali K. Patel, Dan Ramasamy, Senthilvelan Anantharaman, Adrian J. Reber, Shaw M. Akula
Small Molecules in Cancer Therapy: Cytotoxics and Molecularly Targeted Agents
Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 1 Year: 2011 Page: 2-19
Author(s): Anna Blazovics
Signaling Intermediates (PI3K/PTEN/AKT/mTOR and RAF/MEK/ERK Pathways) as Therapeutic Targets for Anti-Cancer and Anti-Angiogenesis Treatments
Journal: Current Signal Transduction Therapy
Volume: 4 Issue: 2 Year: 2009 Page: 130-143
Author(s): Ludovica Ciuffreda, James A. McCubrey, Michele Milella